RecruitingPhase 2NCT06333652
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Maria Lourdes Gonzalez Suarez, MD, PhDMayo Clinic
- Intervention
- Ravulizumab(drug)
- Enrollment
- 14 enrolled
- Eligibility
- 18-50 years · FEMALE
- Timeline
- 2026 – 2028
Study locations (1)
- Mayo Clinic Minnesota, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06333652 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGNANCT07245056Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset PreeclampsiaAnkara Etlik City Hospital
- RECRUITINGPHASE2NCT07041281Spironolactone to Improve Pregnancy-Associated Hypertension TrajectoriesMassachusetts General Hospital
- RECRUITINGNCT07485140Prevention of Preeclampsia in Denmark: A National Implementation StudyCopenhagen University Hospital at Herlev
- RECRUITINGNANCT06893510Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With PreeclampsiaIstanbul University - Cerrahpasa
- RECRUITINGNANCT07261956Lung Ultrasound for the Detection of Volume Overload in Patients With Severe PreeclampsiaSaint Thomas Hospital, Panama
- RECRUITINGNANCT07265336Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant WomenSaint Thomas Hospital, Panama
- RECRUITINGPHASE4NCT07288801Vitamin D for Preventing Recurrent Preeclampsia in Pregnant WomenNishtar Medical University